Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Statin treatment within first 24 hours after heart attack cut mortality by half

Statin treatment within first 24 hours after heart attack cut mortality by half

August 30, 2005

In the largest clinical study of its kind, UCLA researchers found that early treatment with a statin drug within 24 hours of having a heart attack reduced in-hospital mortality rates by over 50 percent.

The new study, published in the Sept. 1 issue of the American Journal of Cardiology, demonstrates that early statin therapy may be essential for reducing mortality and other complications in heart attack victims.




"We've known that long-term statin therapy is beneficial, but this study provides the strongest clinical evidence to date supporting the early cardioprotective effects of statins immediately following a heart attack," said Dr. Gregg C. Fonarow, lead study author, The Eliot Corday Chair in Cardiovascular Medicine and Science and professor of cardiology, David Geffen School of Medicine at UCLA.

Researchers used data from over 170,000 patients taken from the National Registry of Mycocardial Infarction 4, a national database of patients who were admitted to a hospital due to a heart attack.

Researchers found that patients who had received statin therapy before hospitalization and within 24 hours following a heart attack had a 54 percent lower risk of in-hospital mortality compared to patients not on statin therapy.

Patients who had not received previous statin therapy, but who were newly started on the medication within 24 hours of hospitalization had a 58 percent reduction in mortality compared to patients not on statin therapy.

"We were surprised that early statin therapy showed such a striking effect immediately after a heart attack,"said Fonarow, director, Ahmanson-UCLA Cardiomyopathy Center. "We also found that statins provided additional protection from other heart attack complications as well."

The study showed that early statin use was associated with a lower incidence of cardiac arrest, cardiac shock, cardiac rupture and ventricular fibrillation that can all occur following a heart attack.

According to Fonarow, statins work by increasing nitric oxide in the cardiovascular system, which offers a number of benefits including reducing inflammation that may help limit cell damage from a heart attack.

The next step is to develop a clinical trial to corroborate these strong observational findings. Fonarow believes that early statin use within 24 hours of a heart attack may become a standard treatment. "As statins are already routinely started in myocardial infarction patients prior to hospital discharge, it would be relatively easy to administer this medication on arrival to the emergency department." This year 1.5 million Americans will have a new or recurrent heart attack.

University of California-Los Angeles



Related Statins Current Events and Statins News Articles Statins Current Events and Statins News RSS Statins Current Events and Statins News RSS
Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system.

A scientific breakthrough on the control of the bad cholesterol
A study performed by the team of Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology Research Unit at the IRCM, shows for the very first time that the degradation by PCSK9 of the LDLR receptor

Bad cholesterol inhibits the breakdown of peripheral fat
he so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits, according to a study from the Swedish medical university Karolinska Institutet. The discovery reveals a novel function of LDL as a regulator of fat turnover besides its well-established detrimental effects in promoting atherosclerosis.

Vitamin C lowers levels of heart disease biomarker, finds study, adds to debate of health benefits
A new study led by researchers at the University of California, Berkeley, adds to the evidence that vitamin C supplements can lower concentrations of C-reactive protein (CRP), a central biomarker of inflammation that has been shown to be a powerful predictor of heart disease and diabetes.

MSU researcher studies ties between cholesterol drugs, muscle problems
A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users.

Researchers discover new risk factor for cardiovascular disease, and a way to control it
A team of international researchers - including scientists from the McGill University Health Centre (MUHC) and McGill University - have discovered that having high levels of particular protein puts patients at increased risk of developing cardiovascular disease.

Aspirin does not prevent heart attacks in patients with diabetes
Taking regular aspirin and antioxidant supplements does not prevent heart attacks even in high risk groups with diabetes and asymptomatic arterial disease, and aspirin should only be given to patients with established heart disease, stroke or limb arterial disease.

Statins may prevent miscarriages
Hospital for Special Surgery researchers have found that statins may be able to prevent miscarriages in women who are suffering from pregnancy complications caused by antiphospholipid syndrome (APS), according to a study in mice.

New devices used to reduce arterial occlusions, provide cardiac support, highlighted at TCT 2008
Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

Drug may reduce coronary artery plaque
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque.
More Statins Current Events and Statins News Articles


What You Must Know About Statin Drugs & Their Natural Alternatives
by Jay S. Cohen



Statin Drugs Side Effects and the Misguided War on Cholesterol
by M.D. Duane Graveline

If you are on a statin drug or are thinking of going on a statin, this fully referenced book, Statin Drug Side Effects, is a "must read" for you. The unacceptable legacy of statin drug use at today's high doses is a trail of chronic aches and pains, numbness, weakness, confusion, fatigue, shortness of breath and even heart failure in hordes of unsuspecting victims. Only by knowing this...



Natural Alternatives to Lipitor, Zocor & Other Statin Drugs: What to Use And Do to Help Lower Your Bad Cholesterol (Square One Health Guides)
by Jay S. Cohen



Statin Drugs (4 One Hour Interviews)
by Dr. Stan Monteith, Dr. Russell Blaylock, Bill Sardi, Dr. Ray Strand, Shane Ellison

"Statin Drugs" The drug companies are trying to convince us we must lower our cholesterol level below 200, preferably below 170. Is that wise? If you lower your cholesterol level, will you live longer? What do the scientific studies reveal? When will the mistaken idea that cholesterol is the primary cause of heart attacks and strokes finally be discarded into the trash bin of unproven medical...



Statins: Understanding Clinical Use
by Jawahar L. Mehta

Univ. of Arkansas, Little Rock. Pocket-sized reference covers the class of drugs as a whole, discusses the benefits of statin use, and offers future perspectives on ancillary drug actions beyond cholesterol lowering. Addresses the usage of statins as treatment in non-cardiologic events, and more. Softcover. DNLM: Hypercholesterolemia--drug...

Statins show promise for chemoprevention of melanoma: established safety profiles.(Clinical Rounds): An article from: Family Practice News
by Diana Mahoney

This digital document is an article from Family Practice News, published by International Medical News Group on June 15, 2004. The length of the article is 572 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...



Focus on Statin Research

The statins are a relatively new group of drugs used to lower blood cholesterol levels. A high cholesterol level increases a person's risk of having a heart attack or stroke. The long-term use of statins reduces the risk of such an event and can increase the life expectancy of people with a history of heart disease. The statins work by blocking an enzyme in the body that is involved in the...



Statins: The HMG CoA Reductase Inhibitors in Perspective

In the new edition of this popular book, the authors examine the existing and emerging statins and their beneficial effectiveness in reducing serum...



Radio Liberty: Statin Drugs (4 Disc Set)
by Dr. Stanley "Stan" Monteith, Dr. Russell Blaylock, Bill Sardi, Dr. Ray Strand, Shane Ellison

There is much that is still not understood about statins, and it is increasingly apparent that they have a dark side. The major adverse effect of statins is muscle weakness and degradation, called myopathy or rhabdomyolysis, which can range from mild to severe. Understand that among low risk patients, the benefit-to-risk ratio associated with statin use is also lower. Indeed, in low-risk...

Cardiovascular risk profiles improve statin compliance for diabetic patients.(Metabolic Disorders): An article from: Family Practice News
by Damian McNamara

This digital document is an article from Family Practice News, published by International Medical News Group on January 1, 2005. The length of the article is 496 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

© 2008 BrightSurf.com